BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9694006)

  • 1. Early developmental differences between DSM-III-R schizophrenics treated with clozapine and typical neuroleptics.
    Mäkikyrö T; Leinonen E; Koponen H; Järvelin MR; Hakko H; Saarnisaari O; Isohanni M
    J Psychiatr Res; 1998; 32(2):105-10. PubMed ID: 9694006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
    Meltzer HY; Bobo WV; Lee MA; Cola P; Jayathilake K
    Psychiatry Res; 2010 May; 177(3):286-93. PubMed ID: 20378185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of clozapine on cognitive function in schizophrenia.
    Lee MA; Thompson PA; Meltzer HY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():82-7. PubMed ID: 7961582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clozapine and refractory schizophrenia. Long-term prospective study of 20 patients].
    Jalenques I; Coudert AJ
    Encephale; 1994; 20(6):767-75. PubMed ID: 7875111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone as an adjunct to clozapine therapy in chronic schizophrenics.
    Henderson DC; Goff DC
    J Clin Psychiatry; 1996 Sep; 57(9):395-7. PubMed ID: 9746446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia.
    Kim JH; Kim D; Marder SR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):984-8. PubMed ID: 18262321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics.
    Bobo WV; Jayathilake K; Lee MA; Meltzer HY
    Psychiatry Res; 2010 Apr; 176(2-3):114-9. PubMed ID: 20199813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
    Stengler-Wenzke K
    Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of clozapine on smoking in chronic schizophrenic outpatients.
    George TP; Sernyak MJ; Ziedonis DM; Woods SW
    J Clin Psychiatry; 1995 Aug; 56(8):344-6. PubMed ID: 7635849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quality of life of schizophrenic patients and clozapine].
    Raoul Y; Manesse P; Delage M
    Encephale; 1997 Sep; 23 Spec No 4():12-6. PubMed ID: 9417398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gating of auditory P50 in schizophrenics: unique effects of clozapine.
    Nagamoto HT; Adler LE; Hea RA; Griffith JM; McRae KA; Freedman R
    Biol Psychiatry; 1996 Aug; 40(3):181-8. PubMed ID: 8830951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia.
    Kim JH; Kim SY; Ahn YM; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):301-5. PubMed ID: 16309807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effects of a randomized switch of patients from clozaril to generic clozapine.
    Kluznik JC; Walbek NH; Farnsworth MG; Melstrom K
    J Clin Psychiatry; 2001; 62 Suppl 5():14-7; discussion 23-4. PubMed ID: 11305843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study.
    Dursun SM; Szemis A; Andrews H; Whitaker P; Reveley MA
    J Psychiatry Neurosci; 2000 Sep; 25(4):347-52. PubMed ID: 11022399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biogenic amines as predictors of response to clozapine treatment in early-onset schizophrenia.
    Fleischhaker C; Schulz E; Remschmidt H
    J Psychiatr Res; 1998; 32(5):325-33. PubMed ID: 9789212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine for the treatment of adolescents with schizophrenia.
    Birmaher B; Baker R; Kapur S; Quintana H; Ganguli R
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):160-4. PubMed ID: 1537770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study.
    Dursun SM; Szemis A; Andrews H; Reveley MA
    J Psychiatry Neurosci; 1999 Nov; 24(5):453-5. PubMed ID: 10586536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.